Mode
Text Size
Log in / Sign up

Race-neutral CVD risk models show parity gains but create clinical harms for Black adults in cohort studyStudy compares three heart risk models, finds trade-offs in fairness and accuracy

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider that race-neutral CVD risk models may improve parity metrics but can create unintended clinical harms for Black patients.

This retrospective cohort study analyzed 3,241 Black and White adults without known cardiovascular disease (CVD) at baseline, recruited from a community-based longitudinal cohort across multiple U.S. cities. The study compared the predictive performance, calibration, and fairness of three models for 10-year incident CVD: one including race, one substituting social determinants of health (SDoH), and one excluding both race and SDoH (clinical-only). Outcomes were assessed from baseline measures in 2010 through 2021, with a CVD incidence of 6.9% over the follow-up period.

Overall predictive performance was similar across all three models, with area under the curve (AUC) values ranging from 0.762 to 0.768. However, the SDoH-based model improved some parity metrics but led to systematic underprediction and concentrated new overtreatment among Black participants. The clinical-only model further improved parity metrics but generated new undertreatment, resulting in four cases of untreated CVD and no cases of CVD avoided.

The study did not report specific safety or tolerability data related to the models. A key limitation is the observational nature of the analysis, which precludes causal conclusions. The authors emphasize that comprehensive empirical evaluation is necessary before health systems can be confident their model choices serve those most at risk. This research highlights that no single evaluative dimension captured the full equity consequences of switching risk models.

Researchers wanted to see how different ways of calculating heart disease risk affect patients. They studied over 3,200 Black and White adults who did not have known heart disease at the start. The team compared three prediction models: one that included race, one that replaced race with social factors like education and income, and one that used only clinical information like blood pressure and cholesterol. They tracked who developed heart disease over about a decade.

All three models performed similarly in their overall ability to predict who would get heart disease. However, the models that did not use race had important trade-offs. The model using social factors improved some fairness scores but systematically underestimated risk, leading to more Black participants being recommended for treatment when they might not have needed it. The model using only clinical data also improved fairness but missed treating four people who later developed heart disease, all of whom were Black.

The study shows that simply removing race from a risk calculator does not automatically fix fairness problems and can create new ones. The main reason to be careful is that no single measure of fairness or accuracy captured the full picture of how these models would affect different groups of people. Readers should understand that this was a look back at existing data, not a test of new tools in real-time. Health systems will need thorough testing before they can be confident that changing their risk models truly helps those most at risk.

What this means for you:
Removing race from heart risk calculators involves complex trade-offs; more study is needed before changing clinical practice.

Study Details

Study typeCohort
Sample sizen = 3,241
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Importance: Health systems are increasingly adopting race-neutral cardiovascular risk prediction tools, yet no study has examined how these choices redistribute preventive treatment at the point of clinical decision-making, particularly for Black individuals who already bear a disproportionate cardiovascular burden. Objective: To evaluate how including race, substituting social determinants of health (SDoH), or excluding both reshapes cardiovascular risk classification, calibration, fairness, and clinical decisions. Design: Retrospective cohort study with repeated cross-validation and integrated decision-focused evaluation, using CARDIA study data with baseline measures from 2010 and cardiovascular outcomes through 2021. Setting: Community-based longitudinal cohort recruited across multiple U.S. cities. Participants: 3,241 Black and White adults without known cardiovascular disease at baseline. Main Outcomes and Measures: Three models predicting 10-year incident cardiovascular disease were compared on predictive performance, calibration, fairness metrics, and realized clinical utility at the ACC/AHA 7.5% preventive treatment threshold. Results: Among 3,241 participants (46% Black, mean age 50 years, 6.9% CVD incidence), overall performance was similar across models (AUC 0.762 to 0.768). Predictor choice substantially reshaped clinical decisions at the guideline threshold. The SDoH-based model improved parity metrics but produced systematic underprediction and concentrated new overtreatment among Black participants. The clinical-only model further improved parity metrics but generated new undertreatment, with four cases of untreated CVD and none avoided. No single evaluative dimension captured the full equity consequences. Conclusions and Relevance: Parity metrics improved under both race-neutral models, yet both produced clinical harms concentrated among Black participants not apparent in population-average metrics. The case for race removal has rested on conceptual grounds, but comprehensive empirical evaluation is necessary before health systems can be confident their model choices truly serve those most at risk.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.